渤海证券研究所晨会纪要（2025.10.13）-20251013

Macro and Strategy Research - The U.S. government is in a shutdown due to a lack of agreement on a temporary funding bill, leading to a focus on private sector data as official reports are absent. The ADP employment numbers for September showed a larger-than-expected decline, indicating a continued weakening trend in employment. Manufacturing PMI has unexpectedly rebounded but remains in contraction territory, with new orders reflecting weak demand in the manufacturing sector. Non-manufacturing PMI is also not optimistic, with price components slightly rising due to tariff cost transmission [2][3] - In Europe and Japan, political instability is evident with the resignation of the French Prime Minister and the election of a right-leaning leader in Japan, creating uncertainty in the political landscape. The European Central Bank has no immediate plans for rate cuts, while the Bank of Japan's rate hike process may slow down due to policy direction [3] - Domestic consumption has been boosted by the Mid-Autumn Festival and National Day, with service consumption growing faster than goods consumption. However, the real estate market shows signs of weakness, particularly in first-tier cities, and the central bank is expected to adopt a more flexible and anticipatory policy approach in the fourth quarter [2][3] Fixed Income Research - In Q3 2025, the central bank maintained support for the market with significant net injections through reverse repos and MLF, keeping funding prices low. The issuance of government bonds decreased, but net financing remained high due to reduced maturity volumes. The bond market showed a bear steepening trend, with investor confidence in buying bonds remaining low [5][6] - Looking ahead to Q4, the bond market is expected to remain under pressure, but the situation is anticipated to improve compared to Q3. The key indicators to watch include PPI, which will influence bond pricing. The central bank's continued support and potential resumption of bond purchases are expected to stabilize interest rates [6][7] Industry Research Metal Industry - The steel industry is expected to see a gradual recovery in demand post-holiday, but supply may also increase, making significant improvements in the fundamentals unlikely. The upcoming Fourth Plenary Session of the 20th Central Committee is a key event to monitor for industry developments [8] - For copper, global supply remains tight, providing support for prices, but general demand and high prices may pressure future price increases. Aluminum prices are expected to face limitations due to high costs affecting purchasing sentiment [8][9] - Gold prices are influenced by the U.S. entering a rate cut cycle and political risks from the government shutdown. If the shutdown is resolved and economic data remains strong, gold may face short-term corrections [9][10] - Lithium supply concerns have eased with approvals for resource reports, but short-term oversupply pressures may affect prices. Rare earth prices are expected to remain volatile, influenced by domestic export policies and overseas demand [9][10] Pharmaceutical and Biotechnology Industry - The recent World Lung Cancer Conference highlighted the R&D capabilities of Chinese pharmaceutical companies. The National Medical Products Administration has initiated the 11th round of centralized drug procurement [12][13] - The medical care CPI for August showed a 0.9% year-on-year increase, while the pharmaceutical manufacturing PPI decreased by 2.9%. Cumulative revenue and profit in the pharmaceutical manufacturing sector have declined by 2.0% and 3.9%, respectively, in the first eight months of 2025 [13] - The pharmaceutical sector experienced a pullback in September, with a focus on the upcoming ESMO conference and third-quarter earnings reports. There is potential for improvement in fundamentals, particularly in innovative drugs and medical devices [14][15]